Antibiotic-impregnated catheters associated with significant decrease in nosocomial and multidrug-resistant bacteremias in critically III patients

Chest

Volumn 124, Issue 3, 2003, Pages 1030-1038

  Hanna, Hend A ^a   Raad, Issam I ^a   Hackett, Brenda ^a   Wallace, Susannah K ^a   Price, Kristen J ^a   Coyle, D Elizabeth ^a   Parmley, C Lee ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Antibiotic impregnated central venous catheter; Central venous catheters; ICU; Minocycline; Nosocomial bloodstream infections; Rifampin

Indexed keywords

MINOCYCLINE; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BLOOD FLOW; CANCER PATIENT; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; DISEASE ASSOCIATION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; MEDICAL ASSESSMENT; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 0141688426     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.124.3.1030     Document Type: Article

References (28)

1. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. JAMA 1994; 271:1598-1601
2. Edgeworth JD, Treacher DF, Eykyn SJ. A 25-year study of nosocomial bacteremia in an adult intensive care unit. Crit Care Med 1999; 27:1421-1428
3. DiGiovine B, Chenoweth C, Watts C, et al. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 1999; 160:976-981
4. Renaud B, Brun-Buisson C. Outcomes of primary and catheter-related bacteremia: a cohort and case-control study in critically ill patients. Am J Respir Crit Care Med 2001; 163:1584-1590
5. Raad I, Darouiche B, Hachem B, et al. The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin. J Infect Dis 1996; 173:418-424
6. Marik PE, Abraham G, Careau P, et al. The ex vivo antimicrobial activity and colonization rate of two antimicrobial-bonded central venous catheters. Crit Care Med 1999; 27:1128-1131
7. Raad I, Darouiche R, Dupuis J, et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. Ann Intern Med 1997; 127:267-274
8. Darouiche RO, Raad II, Heard SO, et al. A comparison of two antimicrobial-impregnated central venous catheters. N Engl J Med 1999; 340:1-8
9. Farr BM. Antimicrobial catheters: value and safety. Crit Care Med 2000; 28:3366-3367
10. Price KJ, Thall PF, Kish SK, et al. Prognostic indicators for blood and marrow transplant patients admitted to an intensive care unit. Am J Respir Crit Care Med 1998; 158:876-884
11. Groeger JS, Lemeshow S, Price K, et al. Multicenter outcome study of cancer patients admitted to the intensive care unit: a probability of mortality model. J Clin Oncol 1998; 16:761-770
12. Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 1977; 296:1305-1309
13. Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections. Am J Infect Control 1988; 16:128-140
14. Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001; 32:1249-1272
15. Gilliam C, Yamauchi T, Robertson R, et al. Decrease in bloodstream infection rates using an antibiotic impregnated catheter in critical care units of a pediatric hospital [abstract]. Paper presented at: the 40th Annual Meeting of the Infectious Diseases Society of America; New Orleans, LA; September 7 to 10, 2000
16. Dauenhauer SA, Brooks KL, Nelson MS. Analysis of a reduction in bloodstream infections as related to use of untreated vs. silver/chlorhexidine vs. rifampin/minocycline central venous catheters [abstract]. Paper presented at: the 101st Annual Meeting of American Society of Microbiology; Orlando, FL; May 20-24, 2001
17. dos Santos CC, Stewart TE, McGeer A. Anti-microbial or antiseptic impregnated central venous catheters: update on a "central" debate. Intensive Care Med 2000; 26:246-249
18. Tambe SM, Sampath L, Modak SM. In vitro evaluation of the risk of developing bacterial resistance to antiseptics and antibiotics used in medical devices. J Antimicrob Chemother 2001; 47:589J-598J
19. Yourassowsky E, Van der Linden MP, Lismont MJ, et al. Combination of minocycline and rifampin against methicillin and gentamycin resistant Staphylococcus aureus. J Clin Pathol 1981; 34:559-563
20. Fridkin SK, Edwards JR, Courval JM, et al. The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 US adult intensive care units. Ann Intern Med 2001; 135:175-183
21. Fridkin SK, Edwards JR, Pichette SC, et al. Determinants of vancomycin use in adult intensive care units in 41 United States hospitals. Clin Infect Dis 1999; 28:1119-1125
22. Beezhold DW, Slaughter S, Hayden MK, et al. Skin colonization with vancomycin-resistant enterococci among hospitalized patients with bacteremia. Clin Infect Dis 1997; 24:704-706
23. Bassetti S, Hu J, D'Agostino D, et al. In vitro zones of inhibition of coated vascular catheters predict efficacy in preventing catheter infection with Staphylococcus aureus in vivo. Eur J Clin Microbiol Infect Dis 2000; 19:612-617
24. Saint S, Veenstra DL, Lipsky BA. The clinical and economic consequences of nosocomial central venous catheter-related infection: are antimicrobial catheters useful? Infect Control Hosp Epidemiol 2000; 21:375-380
25. Wenzel RP, Edmond MB. The evolving technology of venous access. N Engl J Med 1999; 340:48-50
26. Wenzel RP, Edmond MB. The impact of hospital-acquired bloodstream infections. Emerg Infect Dis 2001; 2001; 7:174-177
27. Marin MG, Lee JC, Skurnik JH. Prevention of nosocomial bloodstream infections: effectiveness of antimicrobial-impregnated and heparin-bonded central venous catheters. Crit Care Med 2000; 28:3332-3338
28. Veenstra DL, Saint S, Sullivan SD. Cost effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection. JAMA 1999; 282:554-560